Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.82 |
| ▸ | LMNA | P02545 | 2/20 | 0.82 |
| ▸ | PKM | P14618 | 2/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.82 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.82 |
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.68 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.62 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA9 | Q16790 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5020960 | 1.00 | ALDH1A1 (0.82) | ALDH1A1LMNAPKMKDM4ESMN1; SMN2 | |
| SCHEMBL578832 | 1.00 | ALDH1A1 (0.82) | ALDH1A1LMNAPKMKDM4ESMN1; SMN2 | |
| SCHEMBL578728 | 1.00 | ALDH1A1 (0.82) | ALDH1A1LMNAPKMKDM4ESMN1; SMN2 | |
| SCHEMBL579136 | 1.00 | ALDH1A1 (0.82) | ALDH1A1LMNAPKMKDM4ESMN1; SMN2 | |
| SCHEMBL1279062 | 1.00 | ALDH1A1 (0.82) | ALDH1A1LMNAPKMKDM4ESMN1; SMN2 | |
| SCHEMBL633906 | 1.00 | ALDH1A1 (0.82) | ALDH1A1LMNAPKMKDM4ESMN1; SMN2 | |
| SCHEMBL366844 | 0.98 | ALDH1A1 (0.79) | ALDH1A1LMNAPKMKDM4ESMN1; SMN2 | |
| Bicarbonate SCHEMBL9492528 | 0.95 | ALDH1A1 (0.74) | ALDH1A1LMNAPKMKDM4ESMN1; SMN2 | |
| Trimethylammonium SCHEMBL27862582 | 0.95 | ALDH1A1 (0.74) | ALDH1A1LMNAPKMKDM4ESMN1; SMN2 | |
| Bicarbonate SCHEMBL9491178 | 0.95 | ALDH1A1 (0.74) | ALDH1A1LMNAPKMKDM4ESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105189508-B | Naphthenic base nitrile Pyrazolopyridine ketone as JANUS kinase inhibitor | 默沙东公司 | 2018-11-23 | — | — | CN | claimed |
| CN-105392816-A | Heat resistant polyethylene terephthalate and a process for the preparation of the same | ESTER IND LTD | 2016-03-09 | — | — | CN | claimed |
| EP-2417198-A1 | POLYAMIDE MATERIAL HAVING HIGH FLUID BARRIER PROPERTIES | Rhodia Opérations (FR) | 2012-02-15 | — | — | EP | claimed |
| WO-2010115951-A1 | POLYAMIDE MATERIAL HAVING HIGH FLUID BARRIER PROPERTIES | RHODIA OPERATIONS (FR) | 2010-10-14 | — | — | WO | claimed |
| US-5922443-A | Polymeric article, such as a medical catheter, and method for making the same | BOSTON SCIENTIFIC GLENS FALLS CORP. | 1999-07-13 | — | — | US | claimed |
| EP-0514913-B1 | A polymeric article, such as a medical catheter, and method for making the same | NAMIC CARIBE INC (PR) | 1997-03-12 | — | — | EP | claimed |
| US-5484565-A | Method for making a medical catheter | NAMIC CARIBE, INC. (PR) | 1996-01-16 | — | — | US | claimed |
| EP-0514913-A2 | A polymeric article, such as a medical catheter, and method for making the same | NAMIC CARIBE, INC. (PR) | 1992-11-25 | — | — | EP | claimed |
| EP-0285946-B1 | N-ALKYL-BENZENE SULFONAMIDES | BAYER AG (DE) | 1991-11-21 | — | — | EP | claimed |
| US-4891156-A | STABILIZED PLASTICIZER | BAYER AKTIENGESELLSCHAFT (DE) | 1990-01-02 | — | — | US | claimed |
| CN-115003756-B | Resin composition | 松下知识产权经营株式会社 | 2024-10-01 | — | — | CN | disclosed |
| US-20230159569-A1 | DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2023-05-25 | — | — | US | disclosed |
| CN-115003756-A | Resin composition | 松下知识产权经营株式会社 | 2022-09-02 | — | — | CN | disclosed |
| US-11174449-B2 | Seal swell agents for lubricating compositions | THE LUBRIZOL CORPORATION (US) | 2021-11-16 | — | — | US | disclosed |
| US-11174449-B2 | Seal swell agents for lubricating compositions | THE LUBRIZOL CORPORATION (US) | 2021-11-16 | — | — | US | disclosed |
| EP-0285946-B1 | N-ALKYL-BENZENE SULFONAMIDES | BAYER AG (DE) | 1991-11-21 | — | — | EP | disclosed |
| US-4891156-A | STABILIZED PLASTICIZER | BAYER AKTIENGESELLSCHAFT (DE) | 1990-01-02 | — | — | US | disclosed |
| EP-0285946-A2 | N-alkyl-benzene sulfonamides | BAYER AG (DE) | 1988-10-12 | — | — | EP | disclosed |
| US-4053458-A | INHIBITORS | UOP INC. (US) | 1977-10-11 | — | — | US | disclosed |
| US-4022828-A | BIS-(SULFONAMIDO)-SULFIDES | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1977-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159569-A1 | DUAL HDAC6/PROTEASOME INHIBITORS, AND METHODS OF USE THEREOF | HDAC6, PSMG3, PSMB2 | ALDH1A1 2269/4885LMNA 2994/4885PKM 2820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.